Management and mitigation of metabolic bone disease and cardiac adverse events throughout the prostate cancer pathway: clinical review and practical recommendations

Drudge-Coates, L., Davey, P., Murray, J. et al. (3 more authors) (2025) Management and mitigation of metabolic bone disease and cardiac adverse events throughout the prostate cancer pathway: clinical review and practical recommendations. Current Medical Research and Opinion, 41 (3). pp. 495-511. ISSN 0300-7995

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Keywords: Prostatic neoplasms; androgen-deprivation therapy; drug-related side effects and adverse reactions; osteoporosis; bone-protecting agents; patient care management; risk management
Dates:
  • Submitted: 25 July 2024
  • Accepted: 19 February 2025
  • Published (online): 7 April 2025
  • Published: 7 April 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 07 Apr 2025 13:59
Last Modified: 14 May 2025 15:30
Status: Published
Publisher: Taylor and Francis Group
Refereed: Yes
Identification Number: 10.1080/03007995.2025.2470755
Open Archives Initiative ID (OAI ID):

Export

Statistics